Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02522988 · ClinicalTrials.gov registry record · NA
The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT02522988: Completed NA study, sponsored by University of Alabama at Birmingham.
NCT02522988 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02522988, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
The purpose of this randomized-controlled, crossover pilot trial is to evaluate the feasibility, acceptability and effects of a non-deceptive (open-label) administration of placebo pills for treating cancer related fatigue (CRF). If significant effects are found, the investigators will later determine if the presence of a COMT Val18Met genotype variant predicts placebo responses.
Primary Outcome
Unit of measure: number of enrollees / number of eligible participants as a measure of feasibility.
Interventions
- BEHAVIORAL Open-label placebo intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2015-06 |
| Est. Completion | 2021-08-01 |
| Phase | NA |
What the finished NCT02522988 record still lists
NCT02522988 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Open-label placebo intervention is the first listed.
NCT02522988 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02522988 about?
NCT02522988 is a clinical study titled "The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors". The purpose of this randomized-controlled, crossover pilot trial is to evaluate the feasibility, acceptability and effects of a non-deceptive (open-label) administration of placebo pills for treating cancer related fatigue (CRF). If significant effects are found, the investigators will later determi...
What is the current status of trial NCT02522988?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2015-06. Estimated completion is 2021-08-01.
What interventions are being tested in trial NCT02522988?
The interventions under investigation include: Open-label placebo intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02522988?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02522988's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia